Join the Thought Leaders Shaping Pharma's Future
A platform for experts, professionals, and industry enthusiasts to share insights, research, and innovations with a global pharma community.

CSO & Executive Director, PharmaDEM Solutions
About
Dr. Ravi S. Ananthula is the Chief Scientific Officer at PharmaDEM Solutions, with a distinguished 19-year career in drug discovery, clinical trials, and product development. His significant achievements include contributing to 8 New Drug Applications (NDAs) and over 20 Abbreviated New Drug Applications (ANDAs). Dr. Ananthula has been a driving force in India's digital transformation in pharmaceuticals through his software innovations, SoluDEM and FormDEM. He has played a crucial role in COVID-19 drug repurposing, developed the first nasal peptide delivery system globally, and advanced peptide synthesis projects. His career includes work with prominent companies such as Eli Lilly and Company, Dr. Reddy's Laboratories, and Aragen, across both the USA and India. Dr. Ananthula is also an active member of the international computational chemistry consortium and holds multiple patents and publications.
Associate Director , Eli Lilly and Company
(June 2020 - June 2022)
Sr. Research Scientist II , Eli Lilly and Company
(November 2018 - June 2020)
Research & Application Scientist , NovaLead Pharma Pvt. Ltd.
(January 2010 - December 2010)
Scientist, Medicinal chemistry & Molecular modelling , GVK BIO
(May 2005 - December 2009)
Associate Principal Scientist, Product development , Dr. Reddy's Laboratories
(January 2014 - June 2016)
A platform for experts, professionals, and industry enthusiasts to share insights, research, and innovations with a global pharma community.
Get most important news delivered to your email inbox